Reduced dose tenecteplase plus tirofiban achieves similar TIMI 3 flow to full dose tenecteplase alone in acute myocardial infarction

Evidence-based Cardiovascular Medicine ◽

10.1016/j.ebcm.2005.09.028 ◽

2005 ◽

Vol 9 (4) ◽

pp. 271-272

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Full Dose ◽

Download Full-text

Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.20101 ◽

2004 ◽

Vol 62 (4) ◽

pp. 445-452 ◽

Author(s):

Aaron Wong ◽

Koon-Hou Mak ◽

Charles Chan ◽

Tian-Hai Koh ◽

Kean-Wah Lau ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Pilot Study ◽

Primary Angioplasty ◽

Asia Pacific ◽

Download Full-text

A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: A pilot study

Journal of the American College of Cardiology ◽

10.1016/0735-1097(89)90095-8 ◽

1989 ◽

Vol 14 (3) ◽

pp. 573-580 ◽

Author(s):

Cindy L Grines ◽

Steven E Nissen ◽

David C Booth ◽

Marcelo C Branco ◽

John C Gurley ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Pilot Study ◽

Plasminogen Activator ◽

Tissue Type ◽

Tissue Type Plasminogen Activator ◽

Full Dose ◽

Type Plasminogen Activator ◽

Download Full-text

Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial

American Heart Journal ◽

10.1016/j.ahj.2007.06.001 ◽

2007 ◽

Vol 154 (4) ◽

pp. 702-709 ◽

Author(s):

Adam B. Greenbaum ◽

E. Magnus Ohman ◽

C. Michael Gibson ◽

Steven Borzak ◽

Amanda L. Stebbins ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Reduced Dose ◽

Receptor Inhibition ◽

Platelet Receptor

Download Full-text

Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial Infarction

JAMA ◽

10.1001/jama.288.17.2130 ◽

2002 ◽

Vol 288 (17) ◽

pp. 2130 ◽

Author(s):

A. Michael Lincoff ◽

Robert M. Califf ◽

Frans Van de Werf ◽

James T. Willerson ◽

Harvey D. White ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Fibrinolytic Therapy ◽

Platelet Glycoprotein ◽

Download Full-text

Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction

The American Journal of Cardiology ◽

10.1016/s0002-9149(02)02241-5 ◽

2002 ◽

Vol 89 (8) ◽

pp. 930-936 ◽

Author(s):

Koon-Hou Mak ◽

Lai-Heng Lee ◽

Aaron Wong ◽

Charles Chan ◽

Tian-Hai Koh ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Thrombin Generation ◽

Download Full-text

A prospective, randomized trial comparing combination half dose tPA with streptokinase to full dose tPA in acute myocardial infarction: Preliminary report

Journal of the American College of Cardiology ◽

10.1016/0735-1097(90)91743-e ◽

1990 ◽

Vol 15 (2) ◽

pp. A4 ◽

Author(s):

Cindy L. Grines ◽

Steven E. Nissen ◽

David C. Booth ◽

John C. Gurley ◽

Noah Chelliah ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Randomized Trial ◽

Preliminary Report ◽

Prospective Randomized Trial ◽

Full Dose ◽

Download Full-text

Safety of adjunctive glycoprotein IIb/IIIa blockade during rescue/early percutaneous coronary intervention following full-dose fibrinolytic therapy for acute myocardial infarction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)82009-0 ◽

2003 ◽

Vol 41 (6) ◽

pp. 332 ◽

Author(s):

Matthew T. Roe ◽

Robert P. Giugliano ◽

Robert Tuttle ◽

Vic Hasselblad ◽

Sabina Murphy ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Fibrinolytic Therapy ◽

Full Dose ◽

Percutaneous Coronary

Download Full-text

Safety of adjunctive glycoprotein IIb/IIIa blockade during rescue/early percutaneous coronary intervention following full-dose fibrinolytic therapy for acute myocardial infarction

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2006.03.013 ◽

2006 ◽

Vol 7 (2) ◽

pp. 85

Author(s):

F. Aslam

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Fibrinolytic Therapy ◽

Full Dose ◽

Percutaneous Coronary

Download Full-text

Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction

American Heart Journal ◽

10.1067/mhj.2001.112239 ◽

2001 ◽

Vol 141 (2) ◽

pp. 218-225 ◽

Author(s):

Philip Jong ◽

Eric A. Cohen ◽

Wayne Batchelor ◽

Charles Lazzam ◽

Catherine Kreatsoulas ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Download Full-text

A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.

Circulation ◽

10.1161/01.cir.84.2.540 ◽

1991 ◽

Vol 84 (2) ◽

pp. 540-549 ◽

Author(s):

C L Grines ◽

S E Nissen ◽

D C Booth ◽

J C Gurley ◽

N Chelliah ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Randomized Trial ◽

Plasminogen Activator ◽

Prospective Randomized Trial ◽

Tissue Type ◽

Tissue Type Plasminogen Activator ◽

Full Dose ◽

Type Plasminogen Activator ◽

Download Full-text